Filing Details
- Accession Number:
- 0001001250-22-000154
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-12 13:08:07
- Reporting Period:
- 2022-09-09
- Accepted Time:
- 2022-09-12 13:08:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001250 | Estee Lauder Companies Inc | EL | Perfumes, Cosmetics & Other Toilet Preparations (2844) | 112408943 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1537679 | P. Carl Haney | The Estee Lauder Companies Inc. 767 Fifth Avenue New York NY 10153 | Evp Research Prod & Innovation | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2022-09-09 | 7,559 | $107.95 | 10,855 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2022-09-09 | 5,109 | $251.86 | 5,746 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2022-09-09 | 2,450 | $252.45 | 3,296 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Option (right to buy) | Disposition | 2022-09-09 | 7,559 | $0.00 | 7,559 | $107.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-09-05 | No | 4 | M | Direct |
Footnotes
- Stock Options granted pursuant to Fiscal 2002 Share Incentive Plan in respect of 7,559 shares exercisable from and after January 1, 2019; 7,559 shares exercisable from and after January 1, 2020; 7,559 shares exercisable from and after January 1, 2021.
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- Sales prices range from $251.26 to $252.24 per share, inclusive.
- Sales prices range from $252.26 to $252.63 per share, inclusive.
- Not applicable.
Billionaire Hedge Funds
